Influence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinoma.
- DOI
- 10.1136/jitc-2021-003026
- Published
- 2022 Feb
- Container
- Journal for immunotherapy of cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/jitc-2021-003026,
title = {Influence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinoma.},
author = {Haddad RI and Seiwert TY and Chow LQM and Gupta S and Weiss J and Gluck I and Eder JP and Burtness B and Tahara M and Keam B and Kang H and Muro K and Albright A and Mogg R and Ayers M and Huang L and Lunceford J and Cristescu R and Cheng J and Mehra R},
year = {2022},
journal = {Journal for immunotherapy of cancer},
doi = {10.1136/jitc-2021-003026},
url = {https://doi.org/10.1136/jitc-2021-003026}
}RIS
TY - JOUR TI - Influence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinoma. AU - Haddad RI AU - Seiwert TY AU - Chow LQM AU - Gupta S AU - Weiss J AU - Gluck I AU - Eder JP AU - Burtness B AU - Tahara M AU - Keam B AU - Kang H AU - Muro K AU - Albright A AU - Mogg R AU - Ayers M AU - Huang L AU - Lunceford J AU - Cristescu R AU - Cheng J AU - Mehra R PY - 2022 JO - Journal for immunotherapy of cancer DO - 10.1136/jitc-2021-003026 UR - https://doi.org/10.1136/jitc-2021-003026 ER -
APA
RI, H., TY, S., LQM, C., S, G., J, W., I, G., JP, E., B, B., M, T., B, K., H, K., K, M., A, A., R, M., M, A., L, H., J, L., R, C., J, C., & R, M. (2022). Influence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinoma.. Journal for immunotherapy of cancer. https://doi.org/10.1136/jitc-2021-003026
Source records
- pubmed · retrieved 2026-09-26T12:28:56.080Z
- europe-pmc · retrieved 2026-09-26T12:28:56.087Z
- doaj · retrieved 2026-09-26T12:28:56.050Z